MDAI earnings: real EPS beat/miss history, analyst consensus Buy, P/E -3.16. Updated 2026-07-23.
Spectral AI (MDAI) Research Hub
Spectral AI (MDAI) trades on NASDAQ, US in the Healthcare (Medical - Specialties) sector. As of 2026-09-11, shares last closed at 1.6 USD (+1.27%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.16, market cap 0.05B. This hub links to the full technical, earnings and options research available for MDAI.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Specialties) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.6 USD (+1.27%) |
| 52-week range | 1.5 USD – 1.9 USD |
| Trend regime | Range |
| 14-day RSI | 31.7 (Bearish) |
| Trailing P/E | -3.16 |
| Market cap | 0.05B |
| Dividend yield | 0.00% |
Available research for MDAI
Covered Call on MDAI: how it works, illustrative setup around the real 1.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MDAI: how it works, illustrative setup around the real 1.6 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MDAI: how it works, illustrative setup around the real 1.6 USD price, max profit/loss, breakeven and when to use it. Educational.
MDAI technical analysis: range, last 1.6 USD, RSI 31.7, 52w range 1.5 USD–1.9 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is MDAI in?
Spectral AI (MDAI) is classified under Healthcare (Medical - Specialties), listed on NASDAQ, US.
Is MDAI in an uptrend or downtrend?
As of 2026-09-11, MDAI is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MDAI's trailing P/E ratio?
MDAI's trailing P/E is -3.16, with a market cap of 0.05B. See the earnings research page for full valuation detail.